Optimizing Intensive Chemotherapy Management in Secondary AML Through Academic Community Collaboration : Episode 2
Opinion
Video
Treatment Goals in Secondary AML
Author(s):
Panelists discuss how secondary acute myeloid leukemia (AML) generally carries a poorer prognosis compared to de novo AML, necessitating careful consideration of treatment goals and open communication with patients about their outlook.
Video content above is prompted by the following:
- What is the prognosis of individuals diagnosed with secondary AML? What do you share with your patients in terms of prognosis?
- What are your treatment goals for secondary AML?
Related Videos
Related Content
